Mohannad O. Khrieba
East Port Said National University
Port Said, PTS, Egypt
Port Said, PTS, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Correction to: Repurposing doxycycline as an adjunct to sitagliptin in type 2 diabetes mellitus: a randomized controlled study on glycemic, inflammatory, and cardiometabolic outcomes.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: July 05, 2026
Repurposing doxycycline as an adjunct to sitagliptin in type 2 diabetes mellitus: a randomized controlled study on glycemic, inflammatory, and cardiometabolic outcomes.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: April 21, 2026
Repurposing doxycycline as an adjunct to sitagliptin in type 2 diabetes mellitus: a randomized controlled study on glycemic, inflammatory, and cardiometabolic outcomes.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: April 21, 2026
Adjunctive Pentoxifylline Enhances Clinical Remission and Reduces Inflammatory Biomarkers in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-Controlled Pilot Trial.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 06, 2026
Interplay of oxidative stress and Inflammasome activation and clinical indices in Parkinson's disease: insights from serum SIRT1, Nrf2, and NLRP3 levels and PDQ-39-a cross-sectional study.
Journal: Frontiers in neuroscience
Published: November 03, 2025
Efficacy of Paroxetine as an Adjuvant Therapy in Rheumatoid Arthritis Patients: A Randomized Controlled Study.
Journal: Drug design, development and therapy
Published: October 08, 2025
Atorvastatin as an immunomodulatory adjunct in ulcerative colitis, beyond lipid lowering to inflammation control: a randomized controlled pilot study.
Journal: Frontiers in pharmacology
Published: August 22, 2025
Clinical study to investigate the adjuvant role of Pentoxifylline in patients with Parkinson's disease: A randomized controlled study.
Journal: International immunopharmacology
Published: January 26, 2025
Repurposing celecoxib as adjuvant therapy in patients with Parkinsonian disease: a new therapeutic dawn: randomized controlled pilot study.
Journal: Inflammopharmacology
Published: August 15, 2024
A randomized placebo-controlled, double-blind study to investigate the effect of a high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients, new insights on serum STAT-3 and hepassocin.
Journal: European review for medical and pharmacological sciences
Published: September 05, 2023
Possible immuno-modulatory effects of tocilizumab in patients with refractory status epilepticus.
Journal: European review for medical and pharmacological sciences
Published: March 06, 2023
Showing 1-11 of 11
Last Updated: 09/26/2026